RESEARCHER PROFILE

Alhan Al‐Khalidi

← Back to Jabir Ibn Hayyan University for Medical and Pharmaceutical Sciences

A

Jabir Ibn Hayyan University for Medical and Pharmaceutical Sciences

COVID-19 Clinical Research StudiesLong-Term Effects of COVID-19SARS-CoV-2 and COVID-19 ResearchCOVID-19 and Mental HealthInflammasome and immune disorders

Alhan Al‐Khalidi works in COVID-19 Clinical Research Studies, Long-Term Effects of COVID-19, SARS-CoV-2 and COVID-19 Research, COVID-19 and Mental Health, Inflammasome and immune disorders. Recorded institutional associations include Jabir Ibn Hayyan University for Medical and Pharmaceutical Sciences.

4Publications
34Citations
3H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. Long-term persistent symptoms of COVID-19 infection in patients with diabetes mellitus

    2021 · 20 citations

  2. Association of ABO blood group with in‐hospital adverse outcome and long term persistent symptoms of COVID‐19 infection: A single‐center longitudinal observational study

    2022 · 10 citations

  3. Hemophagocytic Lymphohistiocytosis syndrome ( HLH ) associated with acute pancreatitis: A case report

    2023 · 4 citations

  4. COVID-19 clinical outcomes in patients with and without ongoing therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers

    2022 · 0 citations

← Return to the university profile